产品编号：B656855
产品规格：10mg
产品价格：面议
| 标准品编号: | B656855 |
| 名称: | N-Boc Tabimorelin |
| 别名: | N-[(2E)-5-[[(1,1-Dimethylethoxy)carbonyl]amino]-5-methyl-1-oxo-2-hexenyl]-N-methyl-3-(2-naphthalenyl)-D-alanyl-N,Nα-dimethyl-D-phenylalaninamide; t-Butyl ((E)-2-Methyl-6-(methyl((R)-1-(methyl((R)-1-(methylamino)-1-oxo-3-phenylpropan-2-yl)amino)-3-(naphthalen-2-yl)-1-oxopropan-2-yl)amino)-6-oxohex-4-en-2-yl)carbamate |
| CAS号: | 193085-20-0 |
| 分子式: | C₃₇H₄₈N₄O₅ |
| 外观: | 白色固体 |
| 分子量: | 628.8 |
| 溶解度: | Dichloromethane |
| 类别: | Standards; Amino Acids; Pharmaceutical/API Drug Impurities/Metabolites; |
| 应用: | N-Boc Tabimorelin is an intermediate in synthesizing Tabimorelin Hemifumarate (T003505), an orally active growth hormone (GH) secretagogue intended for use as an alternative to daily injections of GH. In vitro studies in human liver microsomes have indicated that NN703 is a mechanism-based inhibitor of CYP3A4. |
| 参考文献 | |
